Analytics based on returns data can be a marketing tool for manufacturers
Don't think of reverse logistics as picking up the left-behind, out-of-date stock, or hustling a product recall back up the supply chain; rather, think of these activities as parts of a "collaborative commerce" service. That's part of the reason that Inmar Inc. (Winston-Salem, NC) says that it has succeeded in winning recall and returns business from all of the Big Three wholesalers; these services extend across more than 22,000 retail pharmacies, and more than 70% of the top pharma companies, according to the company. Inmar has been a major player in handling reverse logistics for pharma for some time now—with both a 3,000-strong field service staff, as well as an online order-processing system—but the company is also a leader in managing consumer coupon programs, and provides invoice reconciliation services for manufacturers and retailers inside and outside health services. These interrelated businesses are starting to give Inmar valuable insights into overall customer hehavior and supply chain activity, and those insights can have value to attentive pharma marketers.
According Jeff Pepperworth, president, supply chain and pharmaceutical services, the company's "humble" beginnings in low-margin grocery store returns led to the development of technology suites that drive efficiency. For pharma returns, the featured technology is branded as One Touch Advantage, an arrangement where the multiple steps in a returns process—gathering the physical product, delivering to the wholesaler, manufacturer or ultimate disposer—are reconciled financially in one system. (Conventional returns management often has reimbursements or credits chasing after the physical product, with redundant credit-processing steps along the way; Inmar has competition in this one-touch reconciliation process.) "We have become a trusted partner to our clients," says Pepperworth, "and now we are applying business intelligence tools to the process to drive more waste out of it." Specifically, he says, analytics of the returns process can reduce overstocking and gain better inventory management; down the road, Pepperworth sees tie-ins with coupon programs or patient-compliance programs to help improve medication adherence and patient care.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.